Literature DB >> 33130129

Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors.

Kazuhide Inoue1, Makoto Tsuda2.   

Abstract

Chronic pain is a debilitating condition that often occurs following peripheral tissue inflammation and nerve injury. This pain, especially neuropathic pain, is a significant clinical problem because of the ineffectiveness of clinically available drugs. Since Burnstock proposed new roles of nucleotides as neurotransmitters, the roles of extracellular ATP and P2 receptors (P2Rs) in pain signaling have been extensively studied, and ATP-P2R signaling has subsequently received much attention as it can provide clues toward elucidating the mechanisms underlying chronic pain and serve as a potential therapeutic target. This review summarizes the literature regarding the role of ATP signaling via P2X3Rs (as well as P2X2/3Rs) in primary afferent neurons and via P2X4Rs and P2X7Rs in spinal cord microglia in chronic pain, and discusses their respective therapeutic potentials.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; P2X2/3R; P2X3R; P2X4R; P2X7R; Primary afferent sensory neurons; Spinal cord microglia

Year:  2020        PMID: 33130129     DOI: 10.1016/j.bcp.2020.114309

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway.

Authors:  Masaru Tanaka; Nóra Török; Fanni Tóth; Ágnes Szabó; László Vécsei
Journal:  Biomedicines       Date:  2021-07-26

Review 2.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

3.  Title: P2x7 Receptor Activation and Estrogen Status Drive Neuroinflammatory Mechanisms in a Rat Model for Dry Eye.

Authors:  David A Bereiter; Mostafeezur Rahman; Fabeeha Ahmed; Randall Thompson; Nhungoc Luong; Julie K Olson
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

4.  Suppression of P2X3 receptor-mediated currents by the activation of α2A -adrenergic receptors in rat dorsal root ganglion neurons.

Authors:  Jia-Wei Hao; Wen-Long Qiao; Qing Li; Shuang Wei; Ting-Ting Liu; Chun-Yu Qiu; Wang-Ping Hu
Journal:  CNS Neurosci Ther       Date:  2021-12-04       Impact factor: 5.243

Review 5.  Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease.

Authors:  Carolina Castillo; Francisco Saez-Orellana; Pamela Andrea Godoy; Jorge Fuentealba
Journal:  Front Physiol       Date:  2022-02-23       Impact factor: 4.566

Review 6.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

7.  NMDA and P2X7 Receptors Require Pannexin 1 Activation to Initiate and Maintain Nociceptive Signaling in the Spinal Cord of Neuropathic Rats.

Authors:  David Bravo; Katherine Zepeda-Morales; Carola J Maturana; Jeffri S Retamal; Alejandro Hernández; Teresa Pelissier; Rafael Barra; Patricio Sáez-Briones; Héctor Burgos; Luis Constandil
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

8.  BzATP Activates Satellite Glial Cells and Increases the Excitability of Dorsal Root Ganglia Neurons In Vivo.

Authors:  Zhiyong Chen; Chi Zhang; Xiaodan Song; Xiang Cui; Jing Liu; Neil C Ford; Shaoqiu He; Guangwu Zhu; Xinzhong Dong; Menachem Hanani; Yun Guan
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

Review 9.  The Role of Microglial Purinergic Receptors in Pain Signaling.

Authors:  Hidetoshi Tozaki-Saitoh; Hiroshi Takeda; Kazuhide Inoue
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

10.  P2X7R in Mast Cells is a Potential Target for Salicylic Acid and Aspirin in Treatment of Inflammatory Pain.

Authors:  Yucui Jiang; Fan Ye; Ying Du; Yingxin Zong; Zongxiang Tang
Journal:  J Inflamm Res       Date:  2021-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.